Arvinas (ARVN) News Today $22.69 +1.05 (+4.85%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Arvinas price target lowered to $88 from $90 at BMO CapitalNovember 20 at 10:19 PM | markets.businessinsider.comStephens & Co. Initiates Coverage of Arvinas (ARVN) with Overweight RecommendationNovember 19 at 1:21 PM | msn.comArvinas, Inc. (ARVN): This Small-Cap Stock Is Ready To ExplodeNovember 19 at 10:09 AM | insidermonkey.comArvinas initiated with an Overweight at StephensNovember 18 at 5:16 PM | markets.businessinsider.comStephens Begins Coverage on Arvinas (NASDAQ:ARVN)Stephens assumed coverage on shares of Arvinas in a research report on Monday. They issued an "overweight" rating and a $55.00 price target on the stock.November 18 at 9:05 AM | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Short Interest UpdateArvinas, Inc. (NASDAQ:ARVN - Get Free Report) was the recipient of a large decline in short interest in October. As of October 31st, there was short interest totalling 8,800,000 shares, a decline of 5.6% from the October 15th total of 9,320,000 shares. Based on an average daily volume of 545,500 shares, the days-to-cover ratio is currently 16.1 days.November 18 at 5:14 AM | marketbeat.comClearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular EdemaNovember 7, 2024 | globenewswire.comArvinas, Inc. (NASDAQ:ARVN) Receives Average Rating of "Moderate Buy" from AnalystsArvinas, Inc. (NASDAQ:ARVN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fifteen research firms that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and thirteen have assigned a buyNovember 7, 2024 | marketbeat.comMorgan Stanley Sticks to Their Hold Rating for Arvinas Holding Company (ARVN)November 4, 2024 | markets.businessinsider.comArvinas to Participate in Upcoming Investor ConferencesNovember 4, 2024 | globenewswire.comFY2024 EPS Estimates for Arvinas Cut by Leerink PartnrsArvinas, Inc. (NASDAQ:ARVN - Free Report) - Investment analysts at Leerink Partnrs cut their FY2024 EPS estimates for shares of Arvinas in a report issued on Thursday, October 31st. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings of ($2.70) per share for theNovember 4, 2024 | marketbeat.comArvinas price target lowered to $40 from $50 at OppenheimerNovember 2, 2024 | markets.businessinsider.comAndrew Fein’s Buy Rating for Arvinas: Vepdeg’s Promising Clinical Potential and Market AppealNovember 1, 2024 | markets.businessinsider.comStifel Nicolaus Remains a Buy on Arvinas Holding Company (ARVN)November 1, 2024 | markets.businessinsider.comArvinas (NASDAQ:ARVN) Given Buy Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $87.00 price objective on shares of Arvinas in a research note on Thursday.October 31, 2024 | marketbeat.comArvinas Inc.: Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateOctober 31, 2024 | finanznachrichten.deArvinas Inc (ARVN) Q3 2024: Everything You Need To Know Ahead Of EarningsOctober 31, 2024 | finance.yahoo.comPromising Developments in Arvinas’ Breast Cancer Treatment Pipeline Support Buy RatingOctober 31, 2024 | markets.businessinsider.comArvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ...October 31, 2024 | finance.yahoo.comArvinas Reports Progress in Q3 2024 Financials and TrialsOctober 31, 2024 | markets.businessinsider.comArvinas (NASDAQ:ARVN) Price Target Lowered to $40.00 at OppenheimerOppenheimer decreased their price objective on Arvinas from $50.00 to $40.00 and set an "outperform" rating on the stock in a report on Thursday.October 31, 2024 | marketbeat.comAssenagon Asset Management S.A. Invests $3.44 Million in Arvinas, Inc. (NASDAQ:ARVN)Assenagon Asset Management S.A. acquired a new stake in Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 139,741 shares of the company's stock, valued at approximately $3,442,000. Assenagon AsOctober 31, 2024 | marketbeat.comArvinas (NASDAQ:ARVN) Trading 4.3% Higher - What's Next?Arvinas (NASDAQ:ARVN) Shares Up 4.3% - Still a Buy?October 30, 2024 | marketbeat.comArvinas Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateOctober 30, 2024 | globenewswire.comWhat's Next: Arvinas's Earnings PreviewOctober 30, 2024 | benzinga.comArvinas, Inc. (NASDAQ:ARVN) Sees Significant Drop in Short InterestArvinas, Inc. (NASDAQ:ARVN - Get Free Report) saw a significant drop in short interest in October. As of October 15th, there was short interest totalling 9,320,000 shares, a drop of 12.7% from the September 30th total of 10,670,000 shares. Based on an average trading volume of 581,800 shares, the short-interest ratio is currently 16.0 days.October 29, 2024 | marketbeat.comWe're Hopeful That Arvinas (NASDAQ:ARVN) Will Use Its Cash WiselyOctober 25, 2024 | finance.yahoo.comPromising Advancements in CNS and Oncology Portfolios Drive Buy Rating for ArvinasOctober 23, 2024 | markets.businessinsider.comArvinas (ARVN): A Small-Cap Biotech with High Growth PotentialOctober 23, 2024 | msn.comArvinas (ARVN) to Release Earnings on WednesdayArvinas (NASDAQ:ARVN) will be releasing earnings before the market opens on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=637729)October 23, 2024 | marketbeat.comArvinas Gives Back to Local Greater New Haven Community in Third Annual Impact DayOctober 22, 2024 | globenewswire.comSG Americas Securities LLC Sells 76,236 Shares of Arvinas, Inc. (NASDAQ:ARVN)SG Americas Securities LLC cut its holdings in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 88.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,860 shares of the company's stock after selling 7October 22, 2024 | marketbeat.comArvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024October 21, 2024 | globenewswire.comArvinas, Inc. (ARVN) Stock Price, News, Quote & History - Yahoo FinanceOctober 20, 2024 | finance.yahoo.comArvinas: Major Catalyst Ahead, But Its History Gives Me PauseOctober 16, 2024 | seekingalpha.comArvinas (NASDAQ:ARVN) Trading 5.9% Higher - What's Next?Arvinas (NASDAQ:ARVN) Trading 5.9% Higher - Here's What HappenedOctober 16, 2024 | marketbeat.comShort Interest in Arvinas, Inc. (NASDAQ:ARVN) Drops By 16.4%Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) was the target of a significant drop in short interest during the month of September. As of September 30th, there was short interest totalling 10,670,000 shares, a drop of 16.4% from the September 15th total of 12,760,000 shares. Based on an average daily volume of 647,700 shares, the days-to-cover ratio is currently 16.5 days.October 14, 2024 | marketbeat.comMillennium Management LLC Has $5.33 Million Holdings in Arvinas, Inc. (NASDAQ:ARVN)Millennium Management LLC reduced its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 17.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 200,199 shares of the company's stock after selling 43,46October 12, 2024 | marketbeat.comBuy Rating Affirmed for Arvinas Holding Company Amid Promising Trials and Strategic PositioningOctober 11, 2024 | markets.businessinsider.comThe Manufacturers Life Insurance Company Sells 24,376 Shares of Arvinas, Inc. (NASDAQ:ARVN)The Manufacturers Life Insurance Company trimmed its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 20.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 95,105 shares of the company's stock after selling 24,376 shares duringOctober 10, 2024 | marketbeat.comArvinas (NASDAQ:ARVN) Trading 5.8% Higher - Still a Buy?Arvinas (NASDAQ:ARVN) Trading 5.8% Higher - What's Next?October 8, 2024 | marketbeat.comDimensional Fund Advisors LP Buys 29,635 Shares of Arvinas, Inc. (NASDAQ:ARVN)Dimensional Fund Advisors LP raised its holdings in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 6.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 463,935 shares of the company's stock after buyingOctober 7, 2024 | marketbeat.comArvinas (NASDAQ:ARVN) Shares Down 3.5% Arvinas (NASDAQ:ARVN) Stock Price Down 3.5%October 2, 2024 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Shares Bought by Squarepoint Ops LLCSquarepoint Ops LLC grew its holdings in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 45.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 118,899 shares of the company's stock after acOctober 2, 2024 | marketbeat.comPerceptive Advisors LLC Decreases Holdings in Arvinas, Inc. (NASDAQ:ARVN)Perceptive Advisors LLC trimmed its position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 16.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,027,749 shares of the company's stock after selling 208,854 sharSeptember 30, 2024 | marketbeat.comRenaissance Technologies LLC Reduces Stock Position in Arvinas, Inc. (NASDAQ:ARVN)Renaissance Technologies LLC trimmed its position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 23.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 275,400 shares of the company's stock after sSeptember 26, 2024 | marketbeat.comMagnetar Financial LLC Purchases 22,245 Shares of Arvinas, Inc. (NASDAQ:ARVN)Magnetar Financial LLC grew its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 112.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 41,992 shares of the company's stock after purchasing an additional 22,245 shares during theSeptember 24, 2024 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Shares Bought by Seven Eight Capital LPSeven Eight Capital LP grew its stake in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 576.0% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 39,239 shares of the company's stock after purchasing an additioSeptember 21, 2024 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) have been given an average rating of "Moderate Buy" by the sixteen research firms that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and fourteen have issued a buy ratSeptember 18, 2024 | marketbeat.comArvinas (NASDAQ:ARVN) shareholders have endured a 74% loss from investing in the stock three years agoSeptember 14, 2024 | finance.yahoo.com Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin Related Videos ARVN Media Mentions By Week ARVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARVN News Sentiment▼0.320.45▲Average Medical News Sentiment ARVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARVN Articles This Week▼84▲ARVN Articles Average Week Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNDX News Today PLRX News Today ANNX News Today MORF News Today ENTA News Today BPMC News Today LNTH News Today NUVL News Today CYTK News Today VKTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARVN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arvinas, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arvinas With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARVN Stock Alerts